148 related articles for article (PubMed ID: 32606924)
1. Functions and Clinical Significance of UPF3a Expression in Human Colorectal Cancer.
Bao X; Huang Y; Xu W; Xiong G
Cancer Manag Res; 2020; 12():4271-4281. PubMed ID: 32606924
[TBL] [Abstract][Full Text] [Related]
2. Genetic compensation response could exist in colorectal cancer: UPF3A upregulates the oncogenic homologue gene SRSF3 expression corresponding to SRSF6 to promote colorectal cancer metastasis.
Xu W; Ou W; Feng Y; Xu Q; Yang Y; Cui L; Du P
J Gastroenterol Hepatol; 2023 Apr; 38(4):634-647. PubMed ID: 36807382
[TBL] [Abstract][Full Text] [Related]
3. The clinical significance of CCBE1 expression in human colorectal cancer.
Zhao YR; Liu H; Xiao LM; Jin CG; Zhang ZP; Yang CG
Cancer Manag Res; 2018; 10():6581-6590. PubMed ID: 30555263
[TBL] [Abstract][Full Text] [Related]
4. (Phospho)proteomic Profiling of Microsatellite Unstable CRC Cells Reveals Alterations in Nuclear Signaling and Cholesterol Metabolism Caused by Frameshift Mutation of NMD Regulator UPF3A.
Michalak M; Katzenmaier EM; Roeckel N; Woerner SM; Fuchs V; Warnken U; Yuan YP; Bork P; Neu-Yilik G; Kulozik A; von Knebel Doeberitz M; Kloor M; Kopitz J; Gebert J
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32718059
[TBL] [Abstract][Full Text] [Related]
5. PTC-bearing mRNA elicits a genetic compensation response via Upf3a and COMPASS components.
Ma Z; Zhu P; Shi H; Guo L; Zhang Q; Chen Y; Chen S; Zhang Z; Peng J; Chen J
Nature; 2019 Apr; 568(7751):259-263. PubMed ID: 30944473
[TBL] [Abstract][Full Text] [Related]
6. UPF3A is dispensable for nonsense-mediated mRNA decay in mouse pluripotent and somatic cells.
Chen C; Shen Y; Li L; Ren Y; Wang ZQ; Li T
Life Sci Alliance; 2023 Jun; 6(6):. PubMed ID: 36997282
[TBL] [Abstract][Full Text] [Related]
7. Aberrant expression of stress-induced phosphoprotein 1 in colorectal cancer and its clinicopathologic significance.
Zhang Z; Ren H; Yang L; Zhang X; Liang W; Wu H; Huang L; Kang J; Xu J; Zhai E; Cai S; He Y
Hum Pathol; 2018 Sep; 79():135-143. PubMed ID: 29879402
[TBL] [Abstract][Full Text] [Related]
8. High expression of SLC17A9 correlates with poor prognosis in colorectal cancer.
Yang L; Chen Z; Xiong W; Ren H; Zhai E; Xu K; Yang H; Zhang Z; Ding L; He Y; Song X; Liu J
Hum Pathol; 2019 Feb; 84():62-70. PubMed ID: 30236596
[TBL] [Abstract][Full Text] [Related]
9. Upf3a but not Upf1 mediates the genetic compensation response induced by leg1 deleterious mutations in an H3K4me3-independent manner.
Xie A; Ma Z; Wang J; Zhang Y; Chen Y; Yang C; Chen J; Peng J
Cell Discov; 2023 Jun; 9(1):63. PubMed ID: 37369707
[TBL] [Abstract][Full Text] [Related]
10. Correlation between mitochondrial TRAP-1 expression and lymph node metastasis in colorectal cancer.
Gao JY; Song BR; Peng JJ; Lu YM
World J Gastroenterol; 2012 Nov; 18(41):5965-71. PubMed ID: 23139614
[TBL] [Abstract][Full Text] [Related]
11. CILP2 overexpression correlates with tumor progression and poor prognosis in patients with colorectal cancer in The Cancer Genome Atlas (TCGA) study.
Huang F; Peng Y; Ye Q; Chen J; Li Y; Liu S; Xu Y; Huang L
World J Surg Oncol; 2020 Oct; 18(1):274. PubMed ID: 33099318
[TBL] [Abstract][Full Text] [Related]
12. High expression of AMPD2 and obesity are associated with poor prognosis in colorectal cancer.
Wang F; Liu Y; Jiang J; Qin Y; Ge X; Li J; Qi X; Mao Y
Int J Clin Exp Pathol; 2018; 11(1):216-223. PubMed ID: 31938103
[TBL] [Abstract][Full Text] [Related]
13. Role of MUC20 overexpression as a predictor of recurrence and poor outcome in colorectal cancer.
Xiao X; Wang L; Wei P; Chi Y; Li D; Wang Q; Ni S; Tan C; Sheng W; Sun M; Zhou X; Du X
J Transl Med; 2013 Jun; 11():151. PubMed ID: 23787019
[TBL] [Abstract][Full Text] [Related]
14. Elevated Expression of DLG1 Is Associated with Poor Prognosis in Patients with Colorectal Cancer.
Zhu GD; OuYang S; Liu F; Zhu ZG; Jiang FN; Zhang B
Ann Clin Lab Sci; 2017 Nov; 47(6):657-662. PubMed ID: 29263038
[TBL] [Abstract][Full Text] [Related]
15. Eukaryotic elongation factor-2 kinase expression is an independent prognostic factor in colorectal cancer.
Ng TH; Sham KWY; Xie CM; Ng SSM; To KF; Tong JHM; Liu WYZ; Zhang L; Chan MTV; Wu WKK; Cheng CHK
BMC Cancer; 2019 Jul; 19(1):649. PubMed ID: 31266475
[TBL] [Abstract][Full Text] [Related]
16. FOXM1 expression correlates with tumor invasion and a poor prognosis of colorectal cancer.
Chu XY; Zhu ZM; Chen LB; Wang JH; Su QS; Yang JR; Lin Y; Xue LJ; Liu XB; Mo XB
Acta Histochem; 2012 Dec; 114(8):755-62. PubMed ID: 22326401
[TBL] [Abstract][Full Text] [Related]
17. A Combined four-mRNA Signature Associated with Lymphatic Metastasis for Prognosis of Colorectal Cancer.
Li X; Zhang Q; Zhao L; Jiang L; Qi A; Wei Q; Song X; Wang L; Zhang L; Zhao Y; Lv X; Wei M; Zhao L
J Cancer; 2020; 11(8):2139-2149. PubMed ID: 32127941
[No Abstract] [Full Text] [Related]
18. Relationships among
Wan XB; Wang AQ; Cao J; Dong ZC; Li N; Yang S; Sun MM; Li Z; Luo SX
World J Gastroenterol; 2019 Feb; 25(7):808-823. PubMed ID: 30809081
[TBL] [Abstract][Full Text] [Related]
19. Expression of ubiquitin-conjugating enzyme E2T in colorectal cancers and clinical implications.
Wu X; Liu G; Liu R; He J; Wang G; Zhang H; Liu T; Bai J; Cheng N; Qiu J
Oncol Lett; 2020 Nov; 20(5):275. PubMed ID: 33014154
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of Barx2 predicts poor survival in colorectal cancer.
Mi Y; Zhao S; Zhang W; Zhang D; Weng J; Huang K; Sun H; Tang H; Zhang X; Sun X; Peng Z; Wen Y
Biochem Biophys Res Commun; 2016 Sep; 478(1):67-73. PubMed ID: 27453340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
